The global Neutralizing Antibody Market is estimated to be valued at US$1.62 billion in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights. Neutralizing antibodies are a type of antibody that can bind to specific antigens and inhibit their biological activity. These antibodies play a crucial role in combating viral infections, including the recent COVID-19 ... Read more

Neutralizing antibodies are a type of acquired immune system proteins produced by B cells that can bind to or neutralize pathogenic microbes like viruses or their toxic products, usually by blocking receptor binding or enzymatic activity required for pathogen invasion and spread. There are various medical applications of neutralizing antibody including use in passive immunization to prevent or treat infectious diseases and its emerging popularity in the treatment of COVID-19 infections. ... Read more

Neutralizing antibodies are a type of acquired immune system proteins produced by B cells that can bind to or neutralize pathogenic microbes like viruses or their toxic products, usually by blocking receptor binding or enzymatic activity required for pathogen invasion and spread. There are various medical applications of neutralizing antibody including use in passive immunization to prevent or treat infectious diseases and its emerging popularity in the treatment of COVID-19 infections. ... Read more